Findings from University of Ottawa Reveals New Findings on Cancer (Scalable Biomanufacturing Workflow To Produce and Isolate Natural Killer Cell-derived Extracellular Vesicle- Based Cancer Biotherapeutics).

A recent report from the University of Ottawa discusses the use of natural killer cell-derived extracellular vesicles (NK-EVs) as potential cancer biotherapeutics. These vesicles have unique properties that allow them to target cancer cells and modulate the immune system. The research outlines a scalable biomanufacturing workflow for producing large quantities of high-purity NK-EVs, adhering to Good Manufacturing Practices standards. The study also describes the characterization and functionality assessment of the NK-EVs. The researchers believe that this biomanufacturing process has the potential to advance the clinical translation of NK-EV-based cancer treatments. [Extracted from the article]